37 results
Page 2 of 2
S-3
EX-4.9
5qv m22kr0w3
5 Aug 22
Shelf registration
5:08pm
S-3
my5949okasi9avp obu
5 Aug 22
Shelf registration
5:08pm
8-K
EX-99.1
d9rd9z
26 May 22
Candel Therapeutics Announces Release of Initial Data on CAN-2409 in a Phase 2 Clinical Trial Showing Cytotoxic T Cell Response and Disease Control in Patients with Non-Small Cell Lung Cancer
5:36pm
10-K
zqlf2hqora2cihtv vv4
29 Mar 22
Annual report
8:46am
10-K
EX-10.11
wqtppe4 nt7wz
29 Mar 22
Annual report
8:46am
10-Q
njujlcyj5k rtv
8 Sep 21
Quarterly report
8:37am
424B4
qbsmpbtf1hkume4otg8
28 Jul 21
Prospectus supplement with pricing info
4:02pm
S-1/A
EX-10.10
t5kz8sse
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-1.1
k0gl jq8lw
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
hrbdwejvljhm7gubvj
16 Jul 21
IPO registration (amended)
6:07am
S-1
pto0o7
25 Jun 21
IPO registration
5:28pm
S-1
EX-10.10
peond5qrrqa3gfg mtc
25 Jun 21
IPO registration
5:28pm
DRS/A
6ad2t53q
31 Mar 21
Draft registration statement (amended)
12:00am